APP and Alzheimer disease: Increase in temporal cortex (Silva et al., 2017), CSF (Gaetani et al., 2021) and plasma (Wongchitrat et al., 2019) of AD patients. Pharmacological inhibition reduces cognitive deficits and promote non amyloidogenic processing of APP in 3 x Tg mice (Bai et al., 2022)